recombinant interleukin-12 [clinicaltrials_resource:b4449c10071e683665d523aacee22b45]
Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix [clinicaltrials:NCT00003017]Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors [clinicaltrials:NCT00003107]Interleukin-12 in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003149]Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00003339]Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation [clinicaltrials:NCT00003412]Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma [clinicaltrials:NCT00004260]Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00020449]Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma [clinicaltrials:NCT00031733]Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer [clinicaltrials:NCT00899821]
intervention [clinicaltrials_vocabulary:intervention]
recombinant interleukin-12 [clinicaltrials_resource:b4449c10071e683665d523aacee22b45]
Bio2RDF identifier
b4449c10071e683665d523aacee22b45
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b4449c10071e683665d523aacee22b45
intervention name [clinicaltrials_vocabulary:intervention-name]
recombinant interleukin-12
identifier
clinicaltrials_resource:b4449c10071e683665d523aacee22b45
title
recombinant interleukin-12
@en
type
label
recombinant interleukin-12 [clinicaltrials_resource:b4449c10071e683665d523aacee22b45]
@en